Smartwatch monitoring of vital signs during chemotherapy
Official title: The Use of Proa-active Monitoring by Measuring Vital Signs Using a Fitbit for a 3-month Period Before, During, and After Chemotherapy in Patients With Cancer
Run by Erasmus Medical Center · NCT06680778 · Data updated 2026-11-12
This will try using a Fitbit smartwatch to see if it can detect changes in vital signs in adults with stomach or esophageal cancer during chemotherapy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 175 (estimated) |
| Sponsor | Erasmus Medical Center Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Rotterdam, South Holland) |
| Status | Recruiting |
| Started | July 1, 2025 |
| Main results expected | November 1, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | August 13, 2025 |
| Trial ID | NCT06680778 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with stomach or esophageal cancer who are about to start chemotherapy, can use a Fitbit, speak Dutch, and can give informed consent.
✕Probably not a fit
Patients with cognitive impairment or severe emotional instability, those already enrolled in an exercise trial, or those who cannot use a Fitbit or travel to the center are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center prospective observational project enrolls adults with stomach or esophageal cancer starting systemic chemotherapy at Erasmus MC. Participants begin wearing a Fitbit about a week before their first chemotherapy cycle (target 4–7 days) and are asked to wear it day and night through the first two cycles or up to three months to continuously record vital signs. Investigators review device data at clinic visits at the start of subsequent cycles to compare on-treatment measurements with each patient's baseline. The aim is to see whether a consumer wearable reliably captures chemotherapy-related changes in heart rate, activity, and other parameters that could signal emerging clinical problems.
Why it matters
Potential benefit: If successful, this could enable earlier detection of physiological changes during chemotherapy and prompt timelier clinical follow-up or intervention.
How similar studies have gone: Prior feasibility studies using consumer wearables have shown they can capture activity and heart-rate trends and sometimes flag deterioration, but robust evidence specifically in chemotherapy populations is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years; * Diagnosis of stomach or esophageal cancer with an indication of starting chemotherapy * Knowledge how to handle a Fitbit * Mastery of Dutch language * Able and willing to give written informed consent Exclusion Criteria: * Cognitive disorders or severe emotional instability * Already participating in an exercise trial
Where it's running
-
Erasmus University Medical Center
Rotterdam, South Holland, Netherlands Recruiting
Study contacts
- Study coordinator: Jason den Duijn, MSc.
- Email: j.denduijn@erasmusmc.nl
- Phone: +31107040704
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Help for uninsured kids: connect to NJ FamilyCare in the ED
This ED-based program tries to see if uninsured children can enroll or re-enroll in NJ FamilyCare by giving families direct help and a quick survey about barriers.
-
RightCall: a pediatric sepsis diagnostic toolkit for ED transfer calls
This project will try a toolkit at Children's Hospital Colorado to help clinicians spot sepsis earlier in children who are transferred from general emergency departments.
-
Ambulance-based mobile telemedicine for children with emergencies
This will test whether linking ambulances to remote pediatric emergency doctors by audio-video during transport improves care and outcomes for critically ill children in Karachi.
-
Rapid high-sensitivity Troponin I testing in ambulance care
This tests whether a rapid high-sensitivity troponin I blood test used by ambulance crews helps identify heart attacks earlier in people with chest pain or suspected myocardial infarction.
-
Predicting challenges in laparoscopic appendectomy procedures
This study is testing how to predict challenges during laparoscopic appendectomy surgeries to help train surgical trainees better and improve patient outcomes.
-
Investigation of complications after bariatric surgery in the UK
This study looks at the problems some people face after weight loss surgery in the UK to see how they are treated and what works best for their recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.